FDA Adverse Event Injury Summary report: N

.016 GLIDEWIRE GOLD

MDR report key: 6244 · Received July 27, 1993

Report

Report Number
1219544-1993-00032
Event Type
Injury
Date Received
July 27, 1993
Report Date
June 30, 1993
Manufacturer
TERUMO
Product Code
MKI
Adverse Event
Yes
Report Source
Distributor report
Reporter Location
TX, US
Reporter Occupation
UNKNOWN

Narratives

Description of Event or Problem · 1

THE DISTRIBUTOR BECAME AWARE ON 6/24/93 OF AN INCIDENT THAT OCCURRED APPROXIMATELY SIX WEEKS AGO INVOLVING A GLIDEWIRE GOLD. AN IDENTIFIED TWO (2) FEEDER AVM WAS TO BE AEMBOLIZED PRE SZURGERY USING POLYVINYL ALCHOL. ONE FEEDER, THE MIDDLE CEREBRAL ARTERY WAS SUCCESSFULLY EMBOLIZED WITHOUT INCIDENT. WHILE ATTEMPTING TO GAIN PURCHASE IN THE POSTERIOR CEREBRAL ARTERY SOME DIFFIULTY WAS ENCOUNTERED. A TEST INJECTION OF CONTRAST FOR FLUOROSCOPIC VIEWING EVIDENCED EXTRA VASATION OF CONTRAST MEDIUM INTO THE PARENCHYMA OF THE BRAIN. IT IS BELIEVED THE GLIDEWIRE PERFORATED THE POSTERIOR CEREBRAL ARTERY. THE PATIENT BECAME SYMPTOMATIC DEVELOPING APHASIA. SURGICAL EXCISION OF THE AVM SEVERAL DAYS LATER WAS SUCCESSFUL AND UNEVENTFUL. A FULL RECOVERY WAS EXPERIENCED BY THE PATIENT WITH NO RESIDUAL APHASIA OR OTHER SYMPTOMSDEVICE LABELED FOR SINGLE USE. PATIENT MEDICAL STATUS PRIOR TO EVENT: UNKNOWN. THERE WAS NOT MULTIPLE PATIENT INVOLVEMENT.INVALID DATA - ON DEVICE SERVICE/MAINTENANCE. NO DATA - REGARDING DATE LAST SERVICED. SERVICE PROVIDED BY: INVALID DATA. INVALID DATA - SERVICE RECORDS AVAILABILITY. NO IMMINENT HAZARD TO PUBLIC HEALTH CLAIMED. DEVICE NOT USED AS LABELED/INDENDED.INVALID DATA - REGARDING EVALUATION BY USER AFTER EVENT. METHOD OF EVALUATION: INVALID DATA. RESULTS OF EVALUATION: INVALID DATA. CONCLUSION: INVALID DATA. CERTAINTY OF DEVICE AS CAUSE OF OR CONTRIBUTOR TO EVENT: UNKNOWN (CANNOT DETERMINE). CORRECTIVE ACTIONS: DEVICE DISCARDED. THE DEVICE WAS DESTROYED/DISPOSED OF.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 .016 GLIDEWIRE GOLD GUIDEWIRE MKI TERUMO UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention